Holoprosencephaly (HPE) Cell Models for Research

Holoprosencephaly (HPE) is the most common structural malformation of the forebrain in humans, occurring in 1 in 250 conceptuses and 1 in 10,000 live births (WHO, 2023). The condition results from incomplete cleavage of the embryonic forebrain into two hemispheres, leading to a spectrum of brain and facial anomalies. Severity ranges from alobar HPE (most severe, often fatal in utero) to lobar HPE (milder, with variable survival). The clinical impact is profound: most live-born infants have neurological deficits, including intellectual disability, seizures, and endocrine dysfunction. The 5-year survival rate for severe forms is less than 50% (NCI, 2022). Risk factors include maternal diabetes, alcohol exposure, and genetic mutations. The heterogeneity and incomplete penetrance make HPE a valuable model for studying brain development and gene-environment interactions.

HPE is an ideal model for mechanistic studies of forebrain development and midline patterning. The disease is caused by disruptions in key signaling pathways (SHH, Nodal, and others) that are highly conserved across species. Public datasets, such as those from the International HPE Consortium and DECIPHER, provide extensive genotype-phenotype correlations. Open questions include the role of oligogenic inheritance, modifier genes, and the impact of environmental factors. Gene-edited cell models allow researchers to dissect the function of specific genes in a controlled in vitro system, complementing animal models and patient-derived cells.

While HPE is not a cancer, the underlying signaling pathways are often dysregulated in cancer. The major pathways involved in HPE are:

• • Sonic Hedgehog (SHH) signaling: Critical for ventral forebrain patterning. Mutations in SHH, PTCH1, SMO, and GLI2 disrupt this pathway.
• • Nodal signaling: Essential for left-right asymmetry and midline development. Mutations in NODAL, FOXH1, and GDF1 are implicated.
• • Retinoic acid (RA) signaling: Regulates anterior-posterior patterning. Altered RA metabolism can cause HPE.
• • Notch signaling: Involved in neurogenesis and boundary formation. Mutations in NOTCH2 have been associated with HPE-like phenotypes.

Data from TCGA (not applicable), COSMIC, and ClinVar.

The key signaling networks in HPE include:

• • SHH pathway: SHH ligand binds PTCH1, relieving inhibition of SMO, leading to GLI transcription factor activation. Mutations in SHH, PTCH1, SMO, and GLI2 disrupt this cascade.
• • Nodal pathway: NODAL binds to activin receptors, activating SMAD2/3, which regulate target genes. Mutations in NODAL, FOXH1, and GDF1 impair this signaling.
• • Retinoic acid pathway: RA binds to RAR/RXR nuclear receptors, regulating gene expression. Altered RA synthesis or degradation can cause HPE.
• • Crosstalk: These pathways interact; for example, SHH and Nodal signaling synergize in the ventral forebrain. Disruption of one pathway can affect others.

Organoids derived from hESCs or iPSCs can recapitulate forebrain development and are useful for studying HPE. They allow 3D modeling of SHH signaling and can be genetically edited to introduce disease-relevant mutations.

• • PDX (Patient-Derived Xenograft): Not applicable for HPE as it is not a tumor.
• • GEMM (Genetically Engineered Mouse Models): Shh knockout mice exhibit holoprosencephaly-like phenotypes. Zic2 and Six3 mutant mice also show forebrain defects.
• • Induced models: Chemical inhibition of SHH signaling (e.g., cyclopamine) in chick embryos induces HPE-like features.

CRISPR-Cas9 gene editing enables the creation of isogenic cell lines with specific mutations in HPE-associated genes. For example:

• • SHH knockout cell lines: Loss-of-function models to study SHH signaling deficiency.
• • ZIC2 knockout cell lines: Investigate the role of ZIC2 in forebrain development.
• • SIX3 knock-in cell lines: Introduce patient-specific missense mutations to assess functional impact.

These models are commercially available from various sources, with sequence-verified clones that accelerate research. They are essential for functional validation, drug screening, and mechanistic studies.

Knockout and knock-in lines are used to validate the function of genes implicated in HPE. For example, SHH knockout lines can be used to study downstream target genes and pathway compensation. ZIC2 knockout lines help identify ZIC2-dependent processes in neuronal differentiation. These models enable high-throughput phenotypic assays, such as proliferation, migration, and differentiation.

Isogenic pairs (wild-type vs. mutant) are used for drug screening to identify compounds that rescue the mutant phenotype. For instance, SHH pathway agonists can be tested in SHH knockout lines to see if they restore downstream signaling. Resistance mechanisms can be studied by exposing cells to drugs and selecting for resistant clones, then analyzing genomic changes.

CRISPR synthetic lethality screens can identify genes that are essential only in the context of specific HPE mutations. For example, in SHH-deficient cells, genes in parallel pathways may become essential. These screens can reveal novel therapeutic targets and biomarkers for patient stratification.